8 Recruiting Trials

Clinical Trials for COVID-19 in Iowa

8 clinical trials for COVID-19 are currently recruiting participants at study sites in Iowa. Study-related care is provided at no cost.

Showing 8 of 8 recruiting COVID-19 trials in Iowa

Dime La VerDAD: Verify, Debunk, and Disseminate
NA Iowa City, Iowa +3 sites NCT06417762
Recruiting
COVID-19 Coagulopathy Extension Study
N/A Iowa City, Iowa NCT05334615
Recruiting
Autoimmune Intervention Mastery Course Study
NA Iowa City, Iowa NCT05057676
Recruiting

COVID-19 clinical trials in Iowa: common questions

How many COVID-19 clinical trials are recruiting in Iowa?
TrialFinder currently lists 8 recruiting COVID-19 clinical trials with study sites in Iowa. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are COVID-19 clinical trials located in Iowa?
Study sites for the COVID-19 trials listed on this page include Iowa City, Ames. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a COVID-19 clinical trial in Iowa?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many COVID-19 trials in Iowa also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a COVID-19 clinical trial in Iowa?
Each study sets its own criteria based on age, COVID-19 diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to COVID-19 trials near you in Iowa.

Get Matched — Free
No insurance required

COVID-19 trials study antiviral agents, monoclonal antibodies, long-COVID interventions, and vaccine platforms for prevention and treatment of SARS-CoV-2 infection.

All COVID-19 trials →